The firm is actively filing GranuFlo lawsuits on behalf of those who believe they suffered from the drug’s alleged serious adverse side effects, such as heart attacks and irregular heartbeat.

(PRWEB) January 15, 2014

A lawsuit against Fresenius Medical Care, the manufacturer of GranuFlo, brought by 74 plaintiffs (or their estates, in the cases of those who died from their injuries), has been returned to state court by the federal court to which the defendant had previously removed the matter, according to documents in Agnew v. Fresenius (no. 4:13-2468; United States District Court for the Eastern District of Missouri). A magistrate judge ruled that the federal court does not have proper jurisdiction to hear the case, according to the January 9 remand order.

The plaintiffs, from 27 different states, seek monetary relief for injuries or deaths allegedly resulting from use of GranuFlo dialysis products designed, manufactured, tested, promoted, and sold by Fresenius, according to documents filed in the case. The Rottenstein Law Group LLP, which represents clients in GranuFlo dialysis injury lawsuits, maintains a website at http://www.granuflo-lawsuit.net that features information on GranuFlo side effects and lawsuits.

In June 2012 the U.S. Food and Drug Administration issued a Class 1 Recall after learning about the alleged adverse side effects involving the heart.* The FDA had originally approved the drug for distribution in 2003.

“That the resolution of this matter was delayed by a procedural tacticc ultimately undone by the federal court is unfortunate,” said Rochelle Rottenstein, principal of the Rottenstein Law Group LLP., ”but at least now, with the remand, the Missouri state court can get to the substance of the case.”

The Rottenstein Law Group LLP encourages those who believe they have suffered from the alleged side effects of GranuFlo to read the frequently asked questions and answers about the drug to learn more about its side effects and how to file a lawsuit.

About THE ROTTENSTEIN LAW GROUP LLP
The Rottenstein Law Group LLP is a New York-based firm that represents clients nationwide in mass tort actions. The firm was founded by Rochelle Rottenstein, who has more than two decades of experience as a lawyer, to represent clients hurt by defective medical devices and medications. (Attorney advertising. Prior results do not guarantee a similar outcome.)